Multicentric, Randomized, Double-blind Versus Placebo Study Evaluating the Efficacy of Treatment With Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of Multiple Sclerosis (MS) After a Clinically Isolated Syndrome (CIS). Comparison of Conversion Rates After 2 Years.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Colecalciferol (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms D-Lay-MS
- 19 Dec 2020 Biomarkers information updated
- 05 Jul 2013 Planned End Date changed from 1 Jun 2017 to 1 Jul 2017 as reported by ClinicalTrials.gov.
- 05 Jul 2013 Planned initiation date changed from 1 Jun 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.